Pfizer, Novartis lead $2 billion spending spree on gene therapy production

Pfizer, Novartis lead $2 billion spending spree on gene therapy production

Reuters – Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines. FILE...
Subscribe To Our NewsletterJoin our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!